A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy.
about
The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
P2860
A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A randomized study comparing t ...... ferative diabetic retinopathy.
@ast
A randomized study comparing t ...... ferative diabetic retinopathy.
@en
type
label
A randomized study comparing t ...... ferative diabetic retinopathy.
@ast
A randomized study comparing t ...... ferative diabetic retinopathy.
@en
prefLabel
A randomized study comparing t ...... ferative diabetic retinopathy.
@ast
A randomized study comparing t ...... ferative diabetic retinopathy.
@en
P2093
P1476
A randomized study comparing t ...... ferative diabetic retinopathy.
@en
P2093
Andrew B Merkur
Andrew W Kirker
David A Albiani
Farzin Forooghian
Kaivon Pakzad-Vaezi
Kenneth T Eng
Peter J Kertes
P304
P356
10.3928/23258160-20141118-06
P50
P577
2014-11-01T00:00:00Z